Batimastat injectable inhibitor of matrix metalloproteinase: Received U.K. regulatory approval to resume clinical testing of the agent. Tests had been halted du

British Biotech plc (BBIOY), Oxford, U.K.
Product: Batimastat injectable

Read the full 99 word article

How to gain access

Continue reading with a
two-week free trial.